Gab1, SHP-2 and Other Novel Regulators of Ras: Targets for Anticancer Drug Discovery?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|3|3|177-192

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.3, Iss.3, 2003-06, pp. : 177-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Targets for Anticancer Drug Discovery

By  

Current Drug Targets, Vol. 4, Iss. 2, 2003-02 ,pp. : 159-179

Bentham Science Publishers

Access to resources Recommend Favorite

Leveraging Cell Cycle Analysis in Anticancer Drug Discovery to Identify Novel Plasmodial Drug Targets

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 10, Iss. 3, 2010-01 ,pp. : 165-190

Bentham Science Publishers

Access to resources Recommend Favorite

Signal Transduction Pathway Targets for Anticancer Drug Discovery

By  

Current Pharmaceutical Design, Vol. 6, Iss. 4, 2000-03 ,pp. : 361-378

Bentham Science Publishers

Access to resources Recommend Favorite

STAT proteins as novel targets for cancer drug discovery

By Turkson James  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 5, 2004-10 ,pp. : 409-422

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms of Allostery and Membrane Attachment in Ras GTPases: Implications for Anti-Cancer Drug Discovery

By  

Current Medicinal Chemistry, Vol. 17, Iss. 1, 2010-01 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite